BLOG

Integrating Stem Cell Therapy with Your Current Medical Care

Published 2026.09.04 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Many individuals exploring advanced medical options like regenerative medicine are also managing ongoing health conditions with established treatments. If you are considering adipose-derived stem cell therapy, a common and important question is how it might fit with your current medical care. Integrating a new treatment requires careful planning and communication to ensure safety and continuity of care. This article explains the collaborative approach taken in Japan to safely combine stem cell therapy with existing treatment plans, ensuring a personalized strategy tailored to your unique health situation.

Why Coordination is Crucial for Integrating Treatments

When considering adipose-derived stem cell therapy, especially for those with chronic conditions or who are taking regular medications, a coordinated approach is not just beneficial—it’s essential. The primary goal is to create a comprehensive treatment plan that considers all aspects of your health. Without proper coordination between your regenerative medicine specialist and your primary physician, there is a potential for overlooking critical health information, leading to suboptimal outcomes or safety concerns.

Key concerns that patients often have include:

Will the stem cell therapy interfere with my current medications?
How do I discuss this option with my primary doctor?
Can I continue my existing treatments for conditions like diabetes, hypertension, or autoimmune disorders?
What is the process for international patients seeking care in Japan?

A collaborative framework directly addresses these questions, placing your well-being at the center of the treatment plan.

Understanding Adipose-Derived Stem Cell Therapy

Before exploring how this therapy is integrated, it’s helpful to understand the basics. Adipose-derived stem cell therapy is a form of regenerative medicine that uses mesenchymal stem cells (MSCs) harvested from your own fat tissue. The process involves collecting a small amount of fat, isolating and expanding the MSCs in a specialized facility, and then administering them back into your body, typically through an IV infusion.

MSCs have been reported in numerous studies to possess properties that may help calm inflammation, support tissue repair, and modulate immune system responses. By using your own cells (autologous), the risk of rejection or allergic reactions is considered to be lower compared to using cells from a donor. This treatment is administered on an outpatient basis, allowing it to fit into your daily life without requiring hospitalization.

A Collaborative Approach to Your Treatment Plan

At Grand Green Osaka Umekita Clinic, we believe that integrating stem cell therapy with your existing medical care requires a meticulous, multi-step process. Our approach is founded on open communication and partnership with you and your primary healthcare providers.

1. Comprehensive Initial Assessment
The first step is a thorough consultation. We will review your complete medical history, current health status, ongoing treatments, and all medications you are taking, including supplements. This detailed review helps us understand your unique health profile and identify any potential contraindications or factors that need special consideration.2. Communication with Your Primary Physician
With your consent, we can coordinate with your primary physician or specialists. This collaboration is vital for ensuring continuity of care. We can share our proposed treatment plan and discuss how it complements your existing regimen. This dialogue helps ensure that all members of your healthcare team are aligned and that the stem cell therapy is administered at an appropriate time and in a manner that does not conflict with your other treatments.3. Personalized Treatment Protocol
Based on the comprehensive assessment and communication with your doctor, we design a personalized treatment protocol. This plan is tailored to your specific needs and health goals. It is not a one-size-fits-all approach. The timing, frequency, and dosage of the stem cell administration are carefully planned around your existing medical schedule.4. Continuous Monitoring and Follow-Up
Treatment doesn’t end after the infusion. We provide ongoing monitoring and follow-up to observe your progress. We maintain communication channels with you and, if you wish, with your primary physician to share updates and make any necessary adjustments to your overall care plan.

Preparing for Your Consultation in Japan

For both domestic and international patients (medical tourism), being prepared for your consultation can help make the process smoother and more effective. Before your appointment, it is helpful to gather the following information:

A summary of your medical history and current diagnoses.
A complete list of all medications and supplements you are currently taking, including dosages.
Recent lab results, imaging reports, or other relevant medical records.
Contact information for your primary physician or specialists, should you wish for us to coordinate with them.

Having this information ready allows our physicians to gain a clear and comprehensive understanding of your health, which is the foundation for a safe and personalized treatment plan.

Our Commitment to Safe and Regulated Regenerative Medicine

In Japan, regenerative medicine is provided under strict regulations to ensure safety and quality. Adipose-derived stem cell therapy is offered in compliance with the Act on the Safety of Regenerative Medicine. This means that our treatment plan has been submitted to and accepted by Japan’s Ministry of Health, Labour and Welfare.

It is important to understand that this is an elective treatment not covered by public health insurance (free診療, jiyu-shinryo). The suitability of this therapy, potential risks, side effects, and expected number and duration of treatments must be determined by a physician after a thorough examination. We are committed to providing you with all the necessary information to make an informed decision. For more details on our Adipose-Derived Stem Cell Therapy, we invite you to review our dedicated treatment page.

Learn more about Adipose-Derived Stem Cell Therapy at our clinic.

A Collaborative Path Forward for Your Health

Integrating adipose-derived stem cell therapy with your existing medical care is a thoughtful process that prioritizes your safety and well-being. It is not a replacement for standard medical treatments but can be a complementary option for some individuals. The key to a successful integration lies in a strong, collaborative partnership between you, your primary physician, and our clinical team.

If you are managing a chronic condition and are curious about how regenerative medicine might fit into your long-term health strategy, we encourage you to schedule a consultation. At our clinic in Osaka, we can discuss your individual situation and explore whether a coordinated, personalized treatment plan is a suitable option for you. A final decision on treatment eligibility can only be made after a medical consultation with our physicians.

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›